Is a patient questionnaire without a joint examination as undesirable as a joint examination without a patient questionnaire?

Journal of Rheumatology

Volumn 41, Issue 4, 2014, Pages 619-621

  Pincus, Theodore ^a   Gibson, Kathryn A ^b   Berthelot, Jean Marie M ^c  

^a NYU HOSPITAL FOR JOINT DISEASES   (United States)

^b LIVERPOOL HOSPITAL   (Australia)

^c NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DISEASE ACTIVITY INDEX; CLINICAL EVALUATION; COST CONTROL; DAS28; EDITORIAL; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH CARE COST; HEALTH SERVICE; HEALTH STATUS; HUMAN; JOINT EXAMINATION; MEDICAL HISTORY; PATIENT CARE; PATIENT MONITORING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS; ROUTINE ASSESSMENT OF PATIENT INDEX DATA; SELF REPORT; ARTHRITIS, RHEUMATOID; FEMALE; HEALTH STATUS INDICATOR; INTERNET; MALE; PATHOPHYSIOLOGY; UTILIZATION;

ARTHRITIS, RHEUMATOID; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERNET; MALE; QUESTIONNAIRES; SELF REPORT;

EID: 84897389890     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140074     Document Type: Editorial

References (24)

1. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
2. Pincus T, Strand V, Koch G, Amara I, Crawford B, Wolfe F, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the disease activity score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum 2003;48:625-30.
3. Cohen SB, Strand V, Aguilar D, Ofman JJ. Patient- versus physician-reported outcomes in rheumatoid arthritis patients treated with recombinant interleukin-1 receptor antagonist (anakinra) therapy. Rheumatology 2004;43:704-11.
4. Pincus T, Chung C, Segurado OG, Amara I, Koch GG. An index of patient self-reported outcomes (PRO Index) discriminates effectively between active and control treatment in 4 clinical trials of adalimumab in rheumatoid arthritis. J Rheumatol 2006; 33:2146-52.
5. Pincus T, Bergman MJ, Yazici Y, Hines P, Raghupathi K, Maclean R. An index of only patient-reported outcome measures, routine assessment of patient index data 3 (RAPID3), in two abatacept clinical trials: similar results to disease activity score (DAS28) and other RAPID indices that include physician-reported measures. Rheumatology 2008;47:345-9.
6. Pincus T, Furer V, Keystone E, Yazici Y, Bergman MJ, Luijtens K. RAPID3 (routine assessment of patient index data) severity categories and response criteria: similar results to DAS28 and CDAI in the RAPID1 (rheumatoid arthritis prevention of structural damage) clinical trial of certolizumab pegol (CZP). Arthritis Care Res 2011;63:1142-9.
7. Yelin E, Meenan R, Nevitt M, Epstein W. Work disability in rheumatoid arthritis: effects of disease, social, and work factors. Ann Intern Med 1980;93:551-6.
8. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
9. Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-17.
10. Sokka T, Abelson B, Pincus T. Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 2008;26 Suppl 51:S35-61.
11. Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (routine assessment of patient index data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to DAS and CDAI categories. J Rheumatol 2008;35:2136-47.
12. Pincus T, Swearingen CJ, Bergman MJ, Colglazier CL, Kaell A, Kunath A, et al. RAPID3 on an MDHAQ is correlated significantly with activity levels of DAS28 and CDAI, but scored in 5 versus more than 90 seconds. Arthritis Care Res 2010;62:181-9.
13. Felson DT, Smolen JS, Wells G, Zhang B, van Tuyl LH, Funovits J, et al. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum 2011;63:573-86.
14. Castrejón I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T. Prognosis in ESPOIR rheumatoid arthritis cohort at 24 months according to remission status at 12 months: no differences in radiographic scores according to prior remission status, but significant differences in HAQ scores, highest for Boolean and RAPID3RJ1 criteria [abstract]. Arthritis Rheum 2013;65:S567.
15. Castrejon I, Dougados M, Combe B, Guillemin F, Fautrel B, Pincus T. Can remission in rheumatoid arthritis be assessed without laboratory tests or a formal joint count? Possible remission criteria based on a self-report RAPID3 score and careful joint examination in the ESPOIR cohort. J Rheumatol 2013;40:386-93.
16. Pincus T, Skummer PT, Grisanti MT, Castrejón I, Yazici Y. MDHAQ/RAPID3 can provide a roadmap or agenda for all rheumatology visits when the entire MDHAQ is completed at all patient visits and reviewed by the doctor before the encounter. Bull NYU Hosp Jt Dis 2012;70:177-86.
17. Sokka T, Pincus T. Joint counts to assess rheumatoid arthritis for clinical research and usual clinical care: advantages and limitations. Rheum Dis Clin North Am 2009;35:713-22.
18. Callahan LF, Pincus T. The P-VAS/D-ADL ratio: a clue from a self-report questionnaire to distinguish rheumatoid arthritis from noninflammatory diffuse musculoskeletal pain. Arthritis Rheum 1990;33:1317-22.
19. DeWalt DA, Reed GW, Pincus T. Further clues to recognition of patients with fibromyalgia from a simple 2-page patient multidimensional health assessment questionnaire (MDHAQ). Clin Exp Rheumatol 2004;22:453-61.
20. Castrejón I, Yazici Y, Pincus T. Patient self-report RADAI (Rheumatoid Arthritis Disease Activity Index) joint counts on an MDHAQ (Multidimensional Health Assessment Questionnaire) in usual care of consecutive patients with rheumatic diseases other than rheumatoid arthritis. Arthritis Care Res 2013;65:288-93.
21. Castrejón I, Bergman MJ, Pincus T. MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy and gout. J Clin Rheumatol 2013;19:169-74.
22. Hewlett S, Kirwan J, Pollock J, Mitchell K, Hehir M, Blair PS, et al. Patient initiated outpatient follow up in rheumatoid arthritis: six year randomised controlled trial. Br Med J 2005;330:171-4.
23. Walter MJ, Mohd Din SH, Hazes JM, Lesaffre E, Barendregt PJ, Luime JJ. Is tightly controlled disease activity possible with online patient-reported outcomes? J Rheumatol 2014;41:640-7.
24. Blanchais A, Berthelot JM, Fontenoy AM, le Goff B, Maugars Y. Weekly home self-assessment of RAPID-4/3 scores in rheumatoid arthritis: a 6-month study in 26 patients. Joint Bone Spine 2010;77:582-7.